|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期2014-09-16 |
United States Post-Marketing Observational Cardiovascular Safety Study in Patients Taking Naloxegol
The overall research goal for this study is to provide additional data to characterize the safety of naloxegol in patients aged 18 years and older who do not have a diagnosis of cancer and who are treated with opioids chronically
100 项与 VALINOR PHARMA, LLC 相关的临床结果
0 项与 VALINOR PHARMA, LLC 相关的专利(医药)
100 项与 VALINOR PHARMA, LLC 相关的药物交易
100 项与 VALINOR PHARMA, LLC 相关的转化医学